Zhou YL - Search Results

1

Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta-analysis.

Zhao HL, Chen SZ, Xu HM, Zhou YL, He J, Huang HL, Xu J, Nie YQ. Zhao HL, et al. Among authors: zhou yl. J Dig Dis. 2020 Oct;21(10):534-548. doi: 10.1111/1751-2980.12933. J Dig Dis. 2020. PMID: 33439534

2

Efficacy and safety of infliximab in treating patients with ulcerative colitis: experiences from a single medical center in southern China.

Zhou YL, Xie S, Wang P, Zhang T, Lin MY, Tan JS, Zhi FC, Jiang B, Chen Y. Zhou YL, et al. J Dig Dis. 2014 Sep;15(9):483-90. doi: 10.1111/1751-2980.12161. J Dig Dis. 2014. PMID: 24828856

3

Infliximab for the treatment of Crohn's disease: efficacy and safety in a Chinese single-center retrospective study.

Zhou Y, He H, Wang P, Zhang T, Lin M, Wang H, Nie Y, Chen Y. Zhou Y, et al. Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1270-5. doi: 10.1097/MEG.0000000000000447. Eur J Gastroenterol Hepatol. 2015. PMID: 26275085

4

Association of oncogenic bacteria with colorectal cancer in South China.

Zhou Y, He H, Xu H, Li Y, Li Z, Du Y, He J, Zhou Y, Wang H, Nie Y. Zhou Y, et al. Oncotarget. 2016 Dec 6;7(49):80794-80802. doi: 10.18632/oncotarget.13094. Oncotarget. 2016. PMID: 27821805 Free PMC article.

5

Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.

Zhou Y, Ou Z, Tang X, Zhou Y, Xu H, Wang X, Li K, He J, Du Y, Wang H, Chen Y, Nie Y. Zhou Y, et al. J Cell Mol Med. 2018 Apr;22(4):2263-2271. doi: 10.1111/jcmm.13508. Epub 2018 Feb 7. J Cell Mol Med. 2018. PMID: 29411528 Free PMC article.

6

Linc00483 as ceRNA regulates proliferation and apoptosis through activating MAPKs in gastric cancer.

Li D, Yang M, Liao A, Zeng B, Liu D, Yao Y, Hu G, Chen X, Feng Z, Du Y, Zhou Y, He J, Nie Y. Li D, et al. J Cell Mol Med. 2018 Aug;22(8):3875-3886. doi: 10.1111/jcmm.13661. Epub 2018 May 15. J Cell Mol Med. 2018. PMID: 29761936 Free PMC article.

7

Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression.

Zhou Y, Zheng T, Chen H, Li Y, Huang H, Chen W, Du Y, He J, Li Y, Cao J, Nie Y, Zhou Y. Zhou Y, et al. Cell Physiol Biochem. 2018;51(5):2123-2135. doi: 10.1159/000495830. Epub 2018 Dec 6. Cell Physiol Biochem. 2018. PMID: 30522122 Free article.

8

Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.

Huang HL, Chen HT, Luo QL, Xu HM, He J, Li YQ, Zhou YL, Yao F, Nie YQ, Zhou YJ. Huang HL, et al. Among authors: zhou yl, zhou yj. J Dig Dis. 2019 Aug;20(8):401-408. doi: 10.1111/1751-2980.12756. Epub 2019 Jul 7. J Dig Dis. 2019. PMID: 31070838

9

Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?

Zhou Y, Xu H, Huang H, Li Y, Chen H, He J, Du Y, Chen Y, Zhou Y, Nie Y. Zhou Y, et al. Biomed Res Int. 2019 Jul 29;2019:3469754. doi: 10.1155/2019/3469754. eCollection 2019. Biomed Res Int. 2019. PMID: 31467881 Free PMC article. Review.

10

Characterizing the composition of intestinal microflora by 16S rRNA gene sequencing.

Wang WJ, Zhou YL, He J, Feng ZQ, Zhang L, Lai XB, Zhou JX, Wang H. Wang WJ, et al. Among authors: zhou jx, zhou yl. World J Gastroenterol. 2020 Feb 14;26(6):614-626. doi: 10.3748/wjg.v26.i6.614. World J Gastroenterol. 2020. PMID: 32103871 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

945 results

Search Page

Filters